Both Pfizer and PhRMA funded the Human Rights Campaign’s “Healthcare Equality Index,” a tool that the far-left organization is using to push gender ideology into medical institutions across the nation.
The HRC’s Healthcare Equality Index sways the practices of hospitals and health care facilities by scoring them on whether they are adopting “LGBTQ+ inclusive patient, visitation and employment policies,” the The Washington Free Beacon highlighted in a recent report.
“Over time and due to a decade of advancement in LGBTQ+ inclusion in daily life, health care facilities have worked harder than ever to increase their work to provide equitable care for the LGBTQ+ community,” the HRC boasts, “and now the [Healthcare Equality Index] survey reflects and promotes these efforts through its scoring criteria.”
The Healthcare Equality Index objectives make it clear that to be scored well, health care institutions must prove they are inclusive of LGBTQ patients, cultivating inclusive workplaces by promoting LGBTQ policies and benefits, and engaging publicly with the LGBTQ community.
Inclusivity in those contexts may mean allowing patients or employees to use the restroom that aligns with their gender identity, rather than biological sex, or providing access to “gender-affirming care”—a phrase used by activists to mask the grisly realities of transitioning, including hormones, puberty blockers, and surgeries to remove or “create” breasts, remove or “create” a penis, facial feminization, and more.
Children’s National Hospital in Washington, D.C., earned a perfect score from the Healthcare Equality Index in 2022, the Free Beacon reported. The index uses a 100-point scale and awards points for things like displaying LGBT symbols, using patients’ preferred pronouns, asking what someone’s preferred pronouns are, conducting LGBT training sessions approved by the HRC, and more.
The index also punishes hospitals that allow “discriminatory treatment that is in conflict with their non-discrimination policy” and requires hospitals to offer the same treatments to treat gender dysphoria as the hospital offers to treat other medical conditions. That means, as the Free Beacon noted, that if a hospital uses puberty blockers to treat early puberty, it also must allow their use for children who “identify” as transgender.
The HRC prominently features both Pfizer and PhRMA as funders: “The HEI was funded in part by generous grants from Pfizer Inc. and PhRMA,” its website says, referring to the Pharmaceutical Research and Manufacturers of America, a trade group representing companies in the pharmaceutical industry.
Pfizer did not respond to requests for comment from The Daily Signal. In a statement, PhRMA spokesman Brian Newell said that PhRMA supports and works with “a wide variety of organizations to help promote affordable access to health care.”
“Our work with HRC has primarily focused on issues impacting patient access and affordability, including for those with HIV, cancer, and other deadly diseases,” Newell added. “We were not involved in the development or release of this specific project.”
PhRMA declined to answer further questions about possible conflicts of interest.
Asked why hospitals across the country would implement the diversity, equity, and inclusion recommendations, David Gortler, a former senior adviser to the Food and Drug Administration commissioner and current Ethics and Public Policy Center scholar, told The Daily Signal that “hospitals are no longer run by physicians following scientific evidence anymore; non-physician administrators outrank medical doctors in leadership hierarchy.”
“Hospitals are also too administrator heavy, affecting the practice of medicine,” he explained, noting that academia has the same problem. Gortler pointed to the surprisingly faculty-heavy student-teacher ratios at Yale and Harvard. Many of those people in academia and hospitals nowadays have irrelevant degrees, he suggested, and gain their positions through “H.R. departments, which are also fully saturated with leftists” that “keep hiring DEI people in order to force through unscientific policies.”
“It’s a very pernicious way of altering the practice of medicine,” he said. And the new generations of physicians coming into hospitals are “fully pre-indoctrinated by the aforementioned medical school administrators,” Gortler added.
“These are the next generation of pharmacists, physicians, and nurses, and they’re being taught to specifically ignore fundamentals of biology and data-driven findings,” he emphasized. “They’re not following what science is trying to tell us. That’s a really bad problem.”
Roger Severino, vice president of domestic policy at The Heritage Foundation, told The Daily Signal that Pfizer and PhRMA have turned to an “ideologically driven interest group to do the dirty work” because federal law prohibits them from “directly pushing their dangerous drugs on kids with gender confusion.” (The Daily Signal is the news outlet of The Heritage Foundation.)
“Pfizer and PhRMA are profiting off the broken lives of children who would have come to accept their bodies if only their natural development weren’t interrupted by their drugs,” Severino said. “Yet they continue to pay HRC to bully doctors and insurers into prescribing and paying for puberty blockers and cross-sex hormones that are sold with a smile by Pfizer and PhRMA members. These companies have absolutely no shame.”
Jay Richards, director of the DeVos Center for Life, Religion, and Family at The Heritage Foundation, similarly told The Daily Signal that “it’s a self-evident conflict of interest for private industry groups and drug companies to fund activist organizations that push ideological ‘medicine’ that creates lifelong patients for the drug companies.”
“But what should we say when those same activist organizations create score cards to reward those same drug companies with good publicity?” he asked rhetorically. “It’s hard to imagine a clearer case of cynicism masquerading as virtue.”
Those familiar with the topic will notice the Healthcare Equality Index’s similarities to the Corporate Equality Index, another Human Rights Campaign initiative thought to be behind Bud Light’s financially disastrous decision to use a biological male who “identifies” as a transgender woman, Dylan Mulvaney, as its public face.
Bud Light’s parent company, Anheuser-Busch, formerly was honored with HRC’s “Best Place to Work for LGBTQ+ Equality” title. But HRC removed Anheuser-Busch from the list and suspended its Corporate Equality Index score over Bud Light’s response to public outrage over its promotion of Mulvaney, a biological man, as a woman.
“We don’t make this decision lightly,” Jay Brown, senior vice president of programs, research, and training at the HRC, told Business Insider, citing the growing number of Republican-led bills protecting children from irreversible sex-change surgeries, banning biological males from women’s private spaces, and prohibiting classroom discussions of sexual topics. The HRC opposes such legislation.
“This is about supporting the current and future workforce, as well as shareholders and consumers,” Brown added. “We’ve seen that when businesses center inclusion in both policy and practice, they come out on top, regardless of baseless, hateful attacks.”
HRC also revealed to Business Insider that it had pressured Anheuser-Busch in late April to release a statement supporting Mulvaney. That move came before the HRC’s subsequent punishment: stripping Anheuser-Busch of its score.
Even Fox News follows the directives of the HRC’s Corporate Equality Index, “the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.” The Daily Signal reported this week that for the past several years, Fox has received a perfect score on the Corporate Equality Index, and a former Fox News employee also told The Daily Signal that the company frequently mentions its perfect score in employee-training materials.
According to Fox’s company handbook policies on gender transition, Fox News employees are allowed to use restrooms that align with their gender identity, permitted to dress in alignment with their preferred gender, and must also be addressed by their preferred name and pronouns in the workplace.
The HRC did not immediately respond to requests for comment from The Daily Signal.
Article cross-posted from Daily Signal.
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.